|
DE19836684A1
(en)
|
1998-08-13 |
2000-02-17 |
Hoechst Schering Agrevo Gmbh |
Use of a synergistic herbicidal combination including a glufosinate- or glyphosate-type, imidazolinone or protoporphyrinogen oxidase to control weeds in rice
|
|
KR100338621B1
(en)
*
|
2000-01-24 |
2002-05-30 |
전광술 |
Herbicide and the manufacturing method thereof
|
|
US20070160576A1
(en)
|
2001-06-05 |
2007-07-12 |
Genentech, Inc. |
IL-17A/F heterologous polypeptides and therapeutic uses thereof
|
|
EP1409549A4
(en)
|
2001-06-20 |
2007-10-24 |
Genentech Inc |
COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING TUMORS
|
|
ES2266618T3
(en)
|
2001-08-23 |
2007-03-01 |
Bayer Cropscience S.A. |
SUBSTITUTED PROPARGILAMINS.
|
|
NZ573739A
(en)
|
2001-09-18 |
2010-07-30 |
Genentech Inc |
Compositions and methods for the diagnosis and treatment of tumor, particularly colorectal tumor - TAT201
|
|
US20030228319A1
(en)
|
2002-04-16 |
2003-12-11 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of tumor
|
|
EP1575571A4
(en)
|
2002-01-02 |
2008-06-25 |
Genentech Inc |
COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING A TUMOR
|
|
KR100429139B1
(en)
*
|
2002-02-28 |
2004-04-29 |
한국화학연구원 |
Synergistic herbicidal composition containing cyhalofop-butyl and metamifop as an effective ingredient and method of controling grass weeds
|
|
EP2305710A3
(en)
|
2002-06-03 |
2013-05-29 |
Genentech, Inc. |
Synthetic antibody phage libraries
|
|
PT1610820E
(en)
|
2003-04-04 |
2010-12-16 |
Novartis Ag |
High concentration antibody and protein formulations
|
|
US6849579B2
(en)
*
|
2003-06-25 |
2005-02-01 |
Pbi Gordon Corporation |
Synergistic quinclorac herbicidal compositions
|
|
DK1641822T3
(en)
|
2003-07-08 |
2013-07-22 |
Genentech Inc |
HETEROLOGICAL IL-17-A / F POLYPEPTIDES AND THERAPEUTIC APPLICATIONS THEREOF.
|
|
NZ576411A
(en)
|
2003-11-17 |
2010-04-30 |
Genentech Inc |
Compositions and methods for the treatment of tumor of hematopoietic origin
|
|
JP4570890B2
(en)
*
|
2004-03-26 |
2010-10-27 |
協友アグリ株式会社 |
Herbicidal composition
|
|
US20060051347A1
(en)
|
2004-09-09 |
2006-03-09 |
Winter Charles M |
Process for concentration of antibodies and therapeutic products thereof
|
|
EP3698807A1
(en)
|
2005-01-21 |
2020-08-26 |
Genentech, Inc. |
Fixed dosing of her antibodies
|
|
MX2007010244A
(en)
|
2005-02-23 |
2008-03-10 |
Johnson & Johnson |
Intranasal administration of active agents to the central nervous system.
|
|
US20090136505A1
(en)
|
2005-02-23 |
2009-05-28 |
Johanna Bentz |
Intranasal Administration of Active Agents to the Central Nervous System
|
|
RS53128B
(en)
|
2005-02-23 |
2014-06-30 |
Genentech Inc. |
Extending the time of disease progression or survival in patients with ovarian cancers using PERTUZUMAB
|
|
JP5167473B2
(en)
|
2005-03-03 |
2013-03-21 |
コヴェックス・テクノロジーズ・アイルランド・リミテッド |
Anti-angiogenic compounds
|
|
WO2006132788A2
(en)
|
2005-06-06 |
2006-12-14 |
Genentech, Inc. |
Transgenic models for different genes and their use for gene characterization
|
|
EP1995321A2
(en)
|
2005-08-15 |
2008-11-26 |
Genentech, Inc. |
Gene disruptions, compositions and methods relating thereto
|
|
WO2007081608A2
(en)
|
2005-11-21 |
2007-07-19 |
Genentech, Inc. |
Novel gene disruptions, compositions and methods relating thereto
|
|
CA2638821A1
(en)
|
2006-02-17 |
2007-10-11 |
Genentech, Inc. |
Gene disruptons, compositions and methods relating thereto
|
|
AR060040A1
(en)
|
2006-03-21 |
2008-05-21 |
Genentech Inc |
VEFG AND ALFA5 BETA 1 ANTAGONISTS
|
|
CA2647277A1
(en)
|
2006-04-05 |
2007-11-08 |
Genentech, Inc. |
Method for using boc/cdo to modulate hedgehog signaling
|
|
CA2649387A1
(en)
|
2006-04-19 |
2008-03-27 |
Genentech, Inc. |
Novel gene disruptions, compositions and methods relating thereto
|
|
AU2007319672B2
(en)
|
2006-06-06 |
2011-06-30 |
Genentech, Inc. |
Anti-DLL4 antibodies and methods using same
|
|
US8874380B2
(en)
|
2010-12-09 |
2014-10-28 |
Rutgers, The State University Of New Jersey |
Method of overcoming therapeutic limitations of nonuniform distribution of radiopharmaceuticals and chemotherapy drugs
|
|
CA2660286A1
(en)
|
2006-08-09 |
2008-02-21 |
Homestead Clinical Corporation |
Organ-specific proteins and methods of their use
|
|
EP2471816A1
(en)
|
2006-08-30 |
2012-07-04 |
Genentech, Inc. |
Multispecific antibodies
|
|
BRPI0718591A2
(en)
|
2006-11-10 |
2013-12-03 |
Covx Technologies Ireland Ltd |
ANTIANGIOGENIC COMPOUNDS.
|
|
RU2502806C2
(en)
|
2007-02-22 |
2013-12-27 |
Дженентек, Инк. |
Detection method of intestine inflammatory disease
|
|
US7960139B2
(en)
|
2007-03-23 |
2011-06-14 |
Academia Sinica |
Alkynyl sugar analogs for the labeling and visualization of glycoconjugates in cells
|
|
WO2008154249A2
(en)
|
2007-06-08 |
2008-12-18 |
Genentech, Inc. |
Gene expression markers of tumor resistance to her2 inhibitor treatment
|
|
PE20140625A1
(en)
|
2007-07-16 |
2014-05-29 |
Genentech Inc |
ANTI-CD79b ANTIBODIES AND HUMANIZED IMMUNOCONJUGATES
|
|
PT2474557E
(en)
|
2007-07-16 |
2014-12-03 |
Genentech Inc |
ANTIBODIES AND IMMUNOCONJUGATES ANTI-CD79B AND METHODS OF USE
|
|
KR101620642B1
(en)
|
2007-11-07 |
2016-05-12 |
제넨테크, 인크. |
Methods and compositions for assessing responsiveness of b-cell lymphoma to treatment with anti-cd40 antibodies
|
|
AU2008321016B2
(en)
|
2007-11-12 |
2013-03-28 |
Theraclone Sciences, Inc. |
Compositions and methods for the therapy and diagnosis of influenza
|
|
DK2657253T3
(en)
|
2008-01-31 |
2017-10-09 |
Genentech Inc |
Anti-CD79b antibodies and immune conjugates and methods of use
|
|
JP5544309B2
(en)
|
2008-03-10 |
2014-07-09 |
セラクローン サイエンシーズ, インコーポレイテッド |
Compositions and methods for treatment and diagnosis of cytomegalovirus infection
|
|
NZ601815A
(en)
|
2008-03-31 |
2014-10-31 |
Genentech Inc |
Compositions and methods for treating and diagnosing asthma
|
|
WO2009140684A2
(en)
|
2008-05-16 |
2009-11-19 |
Genentech, Inc. |
Use of biomarkers for assessing treatment of gastrointestinal inflammatory disorders with beta7integrin antagonists
|
|
CN102112490B
(en)
|
2008-07-08 |
2014-10-22 |
昂考梅德药品有限公司 |
Notch1 receptor binding agents and methods of use thereof
|
|
DK2318832T3
(en)
|
2008-07-15 |
2014-01-20 |
Academia Sinica |
Glycan arrays on PTFE-like aluminum coated slides and related methods
|
|
CN101352171B
(en)
*
|
2008-09-19 |
2012-07-04 |
北京燕化永乐农药有限公司 |
Herbicidal compositions of pyrazosulfuron-ethyl and bifenox pesticide
|
|
CA2742871C
(en)
|
2008-11-13 |
2018-10-23 |
Herb Lin |
Methods and compositions for regulating iron homeostasis by modulation of bmp-6
|
|
US8211434B2
(en)
|
2008-11-26 |
2012-07-03 |
Allergan, Inc. |
KLK-13 antibody inhibitor for treating dry eye
|
|
MX356367B
(en)
|
2008-12-09 |
2018-05-25 |
Genentech Inc |
Anti-pd-l1 antibodies and their use to enhance t-cell function.
|
|
SI3260136T1
(en)
|
2009-03-17 |
2021-05-31 |
Theraclone Sciences, Inc. |
Human immunodeficiency virus (hiv) -neutralizing antibodies
|
|
KR20150036824A
(en)
|
2009-03-20 |
2015-04-07 |
제넨테크, 인크. |
Bispecific anti-her antibodies
|
|
MA33256B1
(en)
|
2009-04-01 |
2012-05-02 |
Genentech Inc |
Antibody ,,, fcrh5 and methods of use
|
|
RU2537142C2
(en)
|
2009-04-01 |
2014-12-27 |
Дженентек, Инк. |
Treating diseases related to insulin resistance
|
|
WO2010118243A2
(en)
|
2009-04-08 |
2010-10-14 |
Genentech, Inc. |
Use of il-27 antagonists to treat lupus
|
|
WO2010121231A1
(en)
|
2009-04-18 |
2010-10-21 |
Genentech, Inc. |
Methods for assessing responsiveness of b-cell lymphoma to treatment with anti-cd40 antibodies
|
|
CA2759506A1
(en)
|
2009-04-23 |
2010-10-28 |
Theraclone Sciences, Inc. |
Granulocyte-macrophage colony-stimulating factor (gm-csf) neutralizing antibodies
|
|
CA2762302A1
(en)
|
2009-05-20 |
2010-11-25 |
Theraclone Sciences, Inc. |
Compositions and methods for the therapy and diagnosis of influenza
|
|
US20110038871A1
(en)
|
2009-08-11 |
2011-02-17 |
Veena Viswanth |
Ccr2 inhibitors for treating conditions of the eye
|
|
RU2539772C2
(en)
|
2009-10-22 |
2015-01-27 |
Дженентек, Инк. |
Methods and compositions for hepsin modulation of macrophage-stimulating protein
|
|
WO2011056502A1
(en)
|
2009-10-26 |
2011-05-12 |
Genentech, Inc. |
Bone morphogenetic protein receptor type ii compositions and methods of use
|
|
WO2011056497A1
(en)
|
2009-10-26 |
2011-05-12 |
Genentech, Inc. |
Activin receptor type iib compositions and methods of use
|
|
WO2011056494A1
(en)
|
2009-10-26 |
2011-05-12 |
Genentech, Inc. |
Activin receptor-like kinase-1 antagonist and vegfr3 antagonist combinations
|
|
DK2494356T3
(en)
|
2009-10-26 |
2017-05-15 |
Genentech Inc |
ASSAYS FOR THE DETECTION OF ANTIBODIES SPECIFIC TO THERAPEUTIC ANTI-IGE ANTIBODIES AND THEIR USE OF ANAPHYLAXY
|
|
TWI507524B
(en)
|
2009-11-30 |
2015-11-11 |
建南德克公司 |
Composition and method for diagnosing and treating tumor
|
|
US10087236B2
(en)
|
2009-12-02 |
2018-10-02 |
Academia Sinica |
Methods for modifying human antibodies by glycan engineering
|
|
US11377485B2
(en)
|
2009-12-02 |
2022-07-05 |
Academia Sinica |
Methods for modifying human antibodies by glycan engineering
|
|
US20110159588A1
(en)
|
2009-12-30 |
2011-06-30 |
Kui Lin |
Methods for Modulating a PDGF-AA Mediated Biological Response
|
|
AU2011221226A1
(en)
|
2010-02-23 |
2012-08-16 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of tumor
|
|
WO2011130332A1
(en)
|
2010-04-12 |
2011-10-20 |
Academia Sinica |
Glycan arrays for high throughput screening of viruses
|
|
WO2011133931A1
(en)
|
2010-04-22 |
2011-10-27 |
Genentech, Inc. |
Use of il-27 antagonists for treating inflammatory bowel disease
|
|
BR112012027828A2
(en)
|
2010-05-03 |
2016-08-09 |
Genentech Inc |
matter composition, article of manufacture and method of reducing the viscosity of a protein containing formulation and preparing an aqueous protein containing formulation
|
|
DK2568976T3
(en)
|
2010-05-10 |
2016-01-11 |
Academia Sinica |
Zanamivir-phosphonate congener with the anti-influenza activity, and determining the sensitivity oseltamivir in influenza viruses
|
|
CN102265853A
(en)
*
|
2010-06-04 |
2011-12-07 |
南京华洲药业有限公司 |
Weeding composition containing bentazone and quinclorac, and application thereof
|
|
US20110311527A1
(en)
|
2010-06-16 |
2011-12-22 |
Allergan, Inc. |
IL23p19 ANTIBODY INHIBITOR FOR TREATING OCULAR AND OTHER CONDITIONS
|
|
EP2420250A1
(en)
|
2010-08-13 |
2012-02-22 |
Universitätsklinikum Münster |
Anti-Syndecan-4 antibodies
|
|
EP2603237A4
(en)
|
2010-08-12 |
2014-05-21 |
Theraclone Sciences Inc |
ANTI-HEMAGGLUTININ ANTIBODY COMPOSITIONS AND METHODS OF USE
|
|
JP2013537416A
(en)
|
2010-08-13 |
2013-10-03 |
メディミューン リミテッド |
Monomer polypeptide containing mutant Fc region and method of use
|
|
WO2012022734A2
(en)
|
2010-08-16 |
2012-02-23 |
Medimmune Limited |
Anti-icam-1 antibodies and methods of use
|
|
CA3201524C
(en)
|
2010-08-31 |
2026-01-13 |
International Aids Vaccine Initiative |
Human immunodeficiency virus (hiv)-neutralizing antibodies
|
|
WO2012092539A2
(en)
|
2010-12-31 |
2012-07-05 |
Takeda Pharmaceutical Company Limited |
Antibodies to dll4 and uses thereof
|
|
AU2012217867A1
(en)
|
2011-02-14 |
2013-09-05 |
Theraclone Sciences, Inc. |
Compositions and methods for the therapy and diagnosis of influenza
|
|
AU2012229188A1
(en)
|
2011-03-15 |
2013-09-26 |
Theraclone Sciences, Inc. |
Compositions and methods for the therapy and diagnosis of influenza
|
|
MX2013011130A
(en)
|
2011-03-31 |
2013-10-30 |
Genentech Inc |
Methods of administering beta7 integrin antagonists.
|
|
DK2707031T3
(en)
|
2011-05-08 |
2019-10-07 |
Legochem Biosciences Inc |
PROTEIN-ACTIVE AGENT CONJUGATES AND METHOD FOR PREPARING THE SAME
|
|
CN112225798B
(en)
|
2011-05-17 |
2023-07-18 |
洛克菲勒大学 |
Human immunodeficiency virus neutralizing antibodies and methods of use
|
|
WO2012170071A1
(en)
|
2011-06-06 |
2012-12-13 |
Elan Pharmaceuticas, Inc |
Mcam antagonists and methods of treatment
|
|
JP2013040160A
(en)
|
2011-07-01 |
2013-02-28 |
Genentech Inc |
Use of anti-cd83 agonist antibody for treating autoimmune disease
|
|
US9120858B2
(en)
|
2011-07-22 |
2015-09-01 |
The Research Foundation Of State University Of New York |
Antibodies to the B12-transcobalamin receptor
|
|
WO2013015821A1
(en)
|
2011-07-22 |
2013-01-31 |
The Research Foundation Of State University Of New York |
Antibodies to the b12-transcobalamin receptor
|
|
US9493549B2
(en)
|
2011-07-25 |
2016-11-15 |
The Rockefeller University |
Antibodies directed toward the HIV-1 GP120 CD4 binding site with increased potency and breadth
|
|
US9890207B2
(en)
|
2011-07-25 |
2018-02-13 |
California Institute Of Technology |
Highly active agonistic CD4 binding site anti-HIV antibodies (HAADS) comprising modified CDRH2 regions that improve contact with GP120
|
|
WO2013033069A1
(en)
|
2011-08-30 |
2013-03-07 |
Theraclone Sciences, Inc. |
Human rhinovirus (hrv) antibodies
|
|
US20140050720A1
(en)
|
2012-01-09 |
2014-02-20 |
The Scripps Research Institute |
Ultralong complementarity determining regions and uses thereof
|
|
EP2802601B1
(en)
|
2012-01-09 |
2019-11-13 |
The Scripps Research Institute |
Humanized antibodies with ultralong cdr3s
|
|
WO2013116287A1
(en)
|
2012-01-31 |
2013-08-08 |
Genentech, Inc. |
Anti-ig-e m1' antibodies and methods using same
|
|
WO2013148315A1
(en)
|
2012-03-27 |
2013-10-03 |
Genentech, Inc. |
Diagnosis and treatments relating to her3 inhibitors
|
|
WO2013148232A1
(en)
|
2012-03-27 |
2013-10-03 |
Genentech, Inc. |
Methods of prognosing, diagnosing and treating idiopathic pulmonary fibrosis
|
|
US10130714B2
(en)
|
2012-04-14 |
2018-11-20 |
Academia Sinica |
Enhanced anti-influenza agents conjugated with anti-inflammatory activity
|
|
US9879068B2
(en)
|
2012-06-21 |
2018-01-30 |
California Institute Of Technology |
Antibodies targeting HIV escape mutants
|
|
WO2014018375A1
(en)
|
2012-07-23 |
2014-01-30 |
Xenon Pharmaceuticals Inc. |
Cyp8b1 and uses thereof in therapeutic and diagnostic methods
|
|
US9914956B2
(en)
|
2012-08-18 |
2018-03-13 |
Academia Sinica |
Cell-permeable probes for identification and imaging of sialidases
|
|
JP6211084B2
(en)
|
2012-08-21 |
2017-10-11 |
アカデミア シニカAcademia Sinica |
Benzocyclooctyne compounds and uses thereof
|
|
TWI595007B
(en)
|
2012-09-10 |
2017-08-11 |
Neotope Biosciences Ltd |
Anti-mcam antibodies and associated methods of use
|
|
EP2904015A4
(en)
|
2012-10-02 |
2016-10-05 |
Univ Rutgers |
SPECIFIC ADMINISTRATION OF TOXINS CONJUGATED TO ANTIBODIES UNTIL ACTIVATED MATRIPTASE
|
|
KR101850591B1
(en)
|
2012-10-05 |
2018-04-19 |
제넨테크, 인크. |
Methods for diagnosing and treating inflammatory bowel disease
|
|
PT2908912T
(en)
|
2012-10-18 |
2020-09-04 |
Univ Rockefeller |
Broadly-neutralizing anti-hiv antibodies
|
|
WO2014063205A1
(en)
|
2012-10-26 |
2014-05-01 |
The University Of Queensland |
Use of endocytosis inhibitors and antibodies for cancer therapy
|
|
JP6615745B2
(en)
|
2013-03-27 |
2019-12-04 |
ジェネンテック, インコーポレイテッド |
Use of biomarkers to evaluate treatment of gastrointestinal inflammatory disorders with beta7 integrin antagonists
|
|
US20160053023A1
(en)
|
2013-04-09 |
2016-02-25 |
Annexon, Inc. |
Methods of treatment for neuromyelitis optica
|
|
WO2014210397A1
(en)
|
2013-06-26 |
2014-12-31 |
Academia Sinica |
Rm2 antigens and use thereof
|
|
EP3013347B1
(en)
|
2013-06-27 |
2019-12-11 |
Academia Sinica |
Glycan conjugates and use thereof
|
|
SG11201510316UA
(en)
|
2013-07-09 |
2016-01-28 |
Annexon Inc |
Anti-complement factor c1q antibodies and uses thereof
|
|
JP6687520B2
(en)
|
2013-07-18 |
2020-04-22 |
トーラス バイオサイエンシズ リミテッド ライアビリティ カンパニー |
Humanized antibody with extremely long complementarity determining regions
|
|
WO2015017146A2
(en)
|
2013-07-18 |
2015-02-05 |
Fabrus, Inc. |
Antibodies with ultralong complementarity determining regions
|
|
EP3041484B1
(en)
|
2013-09-06 |
2021-03-03 |
Academia Sinica |
Human inkt cell activation using glycolipids with altered glycosyl groups
|
|
WO2015050959A1
(en)
|
2013-10-01 |
2015-04-09 |
Yale University |
Anti-kit antibodies and methods of use thereof
|
|
BR112016011027A2
(en)
|
2013-12-20 |
2017-12-05 |
Genentech Inc |
method of producing an antibody, antibodies, pharmaceutical composition, polynucleotide, vector, host cell, method of treating asthma and method of treating a disorder
|
|
AU2015206788B2
(en)
|
2014-01-14 |
2019-10-24 |
The Medical College Of Wisconsin, Inc. |
Targeting CLPTM1L for treatment and prevention of cancer
|
|
KR20160104727A
(en)
|
2014-01-16 |
2016-09-05 |
아카데미아 시니카 |
Compositions and methods for treatment and detection of cancers
|
|
US10150818B2
(en)
|
2014-01-16 |
2018-12-11 |
Academia Sinica |
Compositions and methods for treatment and detection of cancers
|
|
WO2015116902A1
(en)
|
2014-01-31 |
2015-08-06 |
Genentech, Inc. |
G-protein coupled receptors in hedgehog signaling
|
|
TWI797430B
(en)
|
2014-03-27 |
2023-04-01 |
中央研究院 |
Reactive labelling compounds and uses thereof
|
|
JP7054990B2
(en)
|
2014-03-27 |
2022-04-15 |
ジェネンテック, インコーポレイテッド |
Methods for Diagnosis and Treatment of Inflammatory Bowel Disease
|
|
CN104012547A
(en)
*
|
2014-05-07 |
2014-09-03 |
广东中迅农科股份有限公司 |
Weed control composition containing pyraclonil and cyhalofop-butyl
|
|
CN104012549B
(en)
*
|
2014-05-07 |
2016-08-17 |
广东中迅农科股份有限公司 |
A kind of containing pyraclonil with the Herbicidal combinations of bispyribac-sodium
|
|
JP6832709B2
(en)
|
2014-05-16 |
2021-02-24 |
メディミューン,エルエルシー |
Molecules with modified neonatal Fc receptor binding for enhanced therapeutic and diagnostic properties
|
|
US10118969B2
(en)
|
2014-05-27 |
2018-11-06 |
Academia Sinica |
Compositions and methods relating to universal glycoforms for enhanced antibody efficacy
|
|
EP4116329A1
(en)
|
2014-05-27 |
2023-01-11 |
Academia Sinica |
Anti-her2 glycoantibodies and uses thereof
|
|
KR20170010003A
(en)
|
2014-05-27 |
2017-01-25 |
아카데미아 시니카 |
Fucosidase from bacteroides and methods using the same
|
|
JP2017518989A
(en)
|
2014-05-27 |
2017-07-13 |
アカデミア シニカAcademia Sinica |
Anti-CD20 glycoengineered antibody group and use thereof
|
|
JP7063538B2
(en)
|
2014-05-28 |
2022-05-09 |
アカデミア シニカ |
Anti-TNFα sugar-manipulated antibody group and its use
|
|
EP3613433B1
(en)
|
2014-05-30 |
2022-01-05 |
Shanghai Henlius Biotech, Inc. |
Anti-epidermal growth factor receptor (egfr) antibodies
|
|
EA201790342A1
(en)
|
2014-08-08 |
2017-07-31 |
ЭЛЕКТОР ЭлЭлСи |
ANTIBODIES TO TREM2 AND METHODS OF THEIR APPLICATION
|
|
EP3191500A4
(en)
|
2014-09-08 |
2018-04-11 |
Academia Sinica |
HUMAN iNKT CELL ACTIVATION USING GLYCOLIPIDS
|
|
CN104255750A
(en)
*
|
2014-09-10 |
2015-01-07 |
广东中迅农科股份有限公司 |
Herbicide composition containing pyraclonil and pretilachlor
|
|
WO2016073157A1
(en)
|
2014-11-06 |
2016-05-12 |
Genentech, Inc. |
Anti-ang2 antibodies and methods of use thereof
|
|
US9975965B2
(en)
|
2015-01-16 |
2018-05-22 |
Academia Sinica |
Compositions and methods for treatment and detection of cancers
|
|
US10495645B2
(en)
|
2015-01-16 |
2019-12-03 |
Academia Sinica |
Cancer markers and methods of use thereof
|
|
BR112017015652B1
(en)
|
2015-01-22 |
2022-06-07 |
BASF Agro B.V. |
Herbicide combination, undesirable vegetation control method and vegetation extermination treatment method
|
|
AU2015378564A1
(en)
|
2015-01-24 |
2017-07-13 |
Academia Sinica |
Novel glycan conjugates and methods of use thereof
|
|
EP3250927B1
(en)
|
2015-01-28 |
2020-02-19 |
H. Hoffnabb-La Roche Ag |
Gene expression markers and treatment of multiple sclerosis
|
|
EP3978530A1
(en)
|
2015-02-26 |
2022-04-06 |
F. Hoffmann-La Roche AG |
Integrin beta7 antagonists and methods of treating crohn's disease
|
|
CN114456272A
(en)
|
2015-04-03 |
2022-05-10 |
优瑞科生物技术公司 |
Constructs targeting AFP peptide/MHC complexes and their uses
|
|
EP3991748A3
(en)
|
2015-04-07 |
2022-08-24 |
Alector LLC |
Anti-sortilin antibodies and methods of use thereof
|
|
CN104757013A
(en)
*
|
2015-04-18 |
2015-07-08 |
广东中迅农科股份有限公司 |
Weeding composition containing pyraclonil, fentrazamide and fenoxaprop-p-ethyl
|
|
WO2016191811A1
(en)
|
2015-06-03 |
2016-12-08 |
The University Of Queensland |
Mobilizing agents and uses therefor
|
|
AU2016276981B2
(en)
|
2015-06-12 |
2022-10-06 |
Alector Llc |
Anti-CD33 antibodies and methods of use thereof
|
|
EP3307779A2
(en)
|
2015-06-12 |
2018-04-18 |
Alector LLC |
Anti-cd33 antibodies and methods of use thereof
|
|
EP3319435B1
(en)
|
2015-07-10 |
2020-02-19 |
BASF Agro B.V. |
Herbicidal composition comprising cinmethylin and clomazone
|
|
US11219212B2
(en)
|
2015-07-10 |
2022-01-11 |
BASF Agro B.V. |
Herbicidal composition comprising cinmethylin and imazamox
|
|
EA201890268A1
(en)
|
2015-07-10 |
2018-07-31 |
Басф Агро Б.В. |
HERBICID COMPOSITION, WHICH CONTAINS CINMETHYLINE AND DIMETENAMIDE
|
|
KR102549057B1
(en)
|
2015-07-10 |
2023-06-29 |
바스프 아그로 비.브이. |
Herbicidal composition comprising cinmethylin and acetochlor or pretilachlor
|
|
CN107846889B
(en)
|
2015-07-10 |
2020-12-08 |
巴斯夫农业公司 |
Herbicidal composition comprising cyptofen and pyroxasulfone
|
|
BR112018000490A2
(en)
|
2015-07-10 |
2018-09-11 |
Basf Agro Bv |
use of (±) -2-exo- (2-methylbenzyloxy) -1-methyl-4-isopropyl-7-oxabicyclo [2.2.1] heptane, undesirable vegetation control method, use and herbicidal composition
|
|
US11219215B2
(en)
|
2015-07-10 |
2022-01-11 |
BASF Agro B.V. |
Herbicidal composition comprising cinmethylin and specific inhibitors of protoporphyrinogen oxidase
|
|
KR20180027580A
(en)
*
|
2015-07-10 |
2018-03-14 |
바스프 아그로 비.브이. |
Herbicide compositions comprising neomycinoline and certain quinolinecarboxylic acids
|
|
DK3319434T3
(en)
|
2015-07-10 |
2019-07-29 |
Basf Agro Bv |
HERBICIDE COMPOSITION CONTAINING CINMETHYLIN AND PETHOXAMIDE
|
|
US20180184658A1
(en)
|
2015-07-10 |
2018-07-05 |
BASF Agro B.V. |
Herbicidal composition comprising cinmethylin and saflufenacil
|
|
CN105076162B
(en)
*
|
2015-08-05 |
2018-03-09 |
安徽华星化工有限公司 |
A kind of Herbicidal composition for rice field containing Oxyfluorfen and pyraclonil
|
|
CN115960235A
(en)
|
2015-08-28 |
2023-04-14 |
艾利妥 |
Anti-SIGLEC-7 antibodies and methods of use thereof
|
|
JP7725185B2
(en)
|
2015-10-06 |
2025-08-19 |
アレクトル エルエルシー |
Anti-TREM2 antibodies and methods of use thereof
|
|
MX2018004721A
(en)
|
2015-10-23 |
2018-07-06 |
Eureka Therapeutics Inc |
CHEMICAL CONSTRUCTIONS ANTIBODY / T-CELL RECEIVER AND USES OF THE SAME.
|
|
SG11201803567XA
(en)
|
2015-10-29 |
2018-05-30 |
Alector Llc |
Anti-siglec-9 antibodies and methods of use thereof
|
|
HUE067016T2
(en)
|
2015-11-25 |
2024-09-28 |
Ligachem Biosciences Inc |
Conjugates containing self-sacrificing groups and related processes
|
|
US10525137B2
(en)
|
2015-12-30 |
2020-01-07 |
Genentech, Inc. |
Formulations with reduced degradation of polysorbate
|
|
JP7023853B2
(en)
|
2016-03-04 |
2022-02-22 |
アレクトル エルエルシー |
Anti-TREM1 antibody and its usage
|
|
CN109195996A
(en)
|
2016-03-08 |
2019-01-11 |
中央研究院 |
Modular synthesis method of N-glycan and array thereof
|
|
CN105901005A
(en)
*
|
2016-05-16 |
2016-08-31 |
河北博嘉农业有限公司 |
Weeding composition containing pyraclonil
|
|
CN105918339A
(en)
*
|
2016-05-19 |
2016-09-07 |
河北博嘉农业有限公司 |
Weeding composition containing pyraclonil and sulfonylurea herbicide
|
|
WO2018014260A1
(en)
|
2016-07-20 |
2018-01-25 |
Nanjing Legend Biotech Co., Ltd. |
Multispecific antigen binding proteins and methods of use thereof
|
|
CA3034057A1
(en)
|
2016-08-22 |
2018-03-01 |
CHO Pharma Inc. |
Antibodies, binding fragments, and methods of use
|
|
SI4339615T1
(en)
|
2016-09-16 |
2026-01-30 |
Shanghai Henlius Biotech, Inc. |
Anti-pd-1 antibodies for use in the treatment of cancer
|
|
WO2018068201A1
(en)
|
2016-10-11 |
2018-04-19 |
Nanjing Legend Biotech Co., Ltd. |
Single-domain antibodies and variants thereof against ctla-4
|
|
CN108064865A
(en)
*
|
2016-11-15 |
2018-05-25 |
江苏龙灯化学有限公司 |
A kind of Herbicidal combinations
|
|
CN108064866A
(en)
*
|
2016-11-15 |
2018-05-25 |
江苏龙灯化学有限公司 |
A kind of Herbicidal combinations
|
|
CN108064868A
(en)
*
|
2016-11-15 |
2018-05-25 |
江苏龙灯化学有限公司 |
A kind of Herbicidal combinations
|
|
CN108064871A
(en)
*
|
2016-11-15 |
2018-05-25 |
江苏龙灯化学有限公司 |
A kind of Herbicidal combinations
|
|
CN108064860A
(en)
*
|
2016-11-15 |
2018-05-25 |
江苏龙灯化学有限公司 |
A kind of Herbicidal combinations
|
|
CN106561695A
(en)
*
|
2016-11-15 |
2017-04-19 |
江苏龙灯化学有限公司 |
Weeding composition
|
|
KR102085798B1
(en)
|
2016-12-28 |
2020-03-06 |
주식회사 인투셀 |
Compounds comprising beta-galactoside self-immolative linker
|
|
TW201831517A
(en)
|
2017-01-12 |
2018-09-01 |
美商優瑞科生物技術公司 |
Construct for targeting tissue protein H3 peptide/MHC complex and use thereof
|
|
WO2018152496A1
(en)
|
2017-02-17 |
2018-08-23 |
The Usa, As Represented By The Secretary, Dept. Of Health And Human Services |
Compositions and methods for the diagnosis and treatment of zika virus infection
|
|
CN106857580A
(en)
*
|
2017-02-27 |
2017-06-20 |
南京华洲药业有限公司 |
A kind of Herbicidal combinations and its application containing pyraclonil and diflufenican
|
|
CN107047592A
(en)
*
|
2017-02-27 |
2017-08-18 |
南京华洲药业有限公司 |
A kind of Herbicidal combinations and its application containing pyraclonil and bensulfuron-methyl
|
|
CN106857579A
(en)
*
|
2017-02-27 |
2017-06-20 |
南京华洲药业有限公司 |
A kind of Herbicidal combinations and its application containing pyraclonil and triaziflam
|
|
CN106857575A
(en)
*
|
2017-02-27 |
2017-06-20 |
南京华洲药业有限公司 |
A kind of Herbicidal combinations and its application containing pyraclonil and butachlor
|
|
CN107047594A
(en)
*
|
2017-02-27 |
2017-08-18 |
南京华洲药业有限公司 |
A kind of Herbicidal combinations and its application containing pyraclonil and halosulfuronmethyl
|
|
CN106857577A
(en)
*
|
2017-02-27 |
2017-06-20 |
南京华洲药业有限公司 |
A kind of Herbicidal combinations and its application containing pyraclonil and dithiopyr
|
|
CN106889094A
(en)
*
|
2017-02-27 |
2017-06-27 |
南京华洲药业有限公司 |
A kind of Herbicidal combinations and its application containing pyraclonil and pyrazosulfuron
|
|
CN106857578A
(en)
*
|
2017-02-27 |
2017-06-20 |
南京华洲药业有限公司 |
A kind of Herbicidal combinations and its application containing pyraclonil and Acetochlor
|
|
CN107047593A
(en)
*
|
2017-02-27 |
2017-08-18 |
南京华洲药业有限公司 |
A kind of Herbicidal combinations and its application containing pyraclonil and ethoxysulfuron
|
|
CN107047578A
(en)
*
|
2017-02-27 |
2017-08-18 |
南京华洲药业有限公司 |
A kind of Herbicidal combinations and its application containing pyraclonil and oxadiargyl
|
|
CN106889084A
(en)
*
|
2017-02-27 |
2017-06-27 |
南京华洲药业有限公司 |
A kind of Herbicidal combinations and its application containing pyraclonil and bentazone
|
|
CN106857600A
(en)
*
|
2017-02-27 |
2017-06-20 |
南京华洲药业有限公司 |
A kind of Herbicidal combinations and its application containing pyraclonil and isoproturon
|
|
CN106889082A
(en)
*
|
2017-02-27 |
2017-06-27 |
南京华洲药业有限公司 |
A kind of Herbicidal combinations of the Evil of Yu containing pyraclonil humulones and its application
|
|
CN106857576A
(en)
*
|
2017-02-27 |
2017-06-20 |
南京华洲药业有限公司 |
A kind of Herbicidal combinations and its application containing pyraclonil and mefenacet
|
|
CN106889083B
(en)
*
|
2017-02-27 |
2019-02-12 |
南京华洲药业有限公司 |
A kind of herbicidal composition containing pyraclostrobin and clomazone and application thereof
|
|
CN107047582A
(en)
*
|
2017-02-27 |
2017-08-18 |
南京华洲药业有限公司 |
A kind of Herbicidal combinations and its application containing pyraclonil and esprocarb
|
|
CN106857621A
(en)
*
|
2017-02-27 |
2017-06-20 |
南京华洲药业有限公司 |
A kind of Herbicidal combinations and its application containing pyraclonil and molinate
|
|
CN106857609A
(en)
*
|
2017-02-27 |
2017-06-20 |
南京华洲药业有限公司 |
A kind of Herbicidal combinations and its application containing pyraclonil and ethoxysulfuron
|
|
RU2665790C1
(en)
|
2017-04-17 |
2018-09-04 |
Закрытое Акционерное Общество "Биокад" |
Monoclonal pd-l1 antibody
|
|
EP4230649A3
(en)
|
2017-04-25 |
2023-10-25 |
The U.S.A. As Represented By The Secretary, Department Of Health And Human Services |
Antibodies and methods for the diagnosis and treatment of epstein barr virus infection
|
|
WO2018200582A1
(en)
|
2017-04-26 |
2018-11-01 |
Eureka Therapeutics, Inc. |
Chimeric antibody/t-cell receptor constructs and uses thereof
|
|
EP3615574B1
(en)
|
2017-04-26 |
2026-06-24 |
Eureka Therapeutics, Inc. |
Constructs specifically recognizing glypican 3 and uses thereof
|
|
EP3625258A1
(en)
|
2017-05-16 |
2020-03-25 |
Alector LLC |
Anti-siglec-5 antibodies and methods of use thereof
|
|
CN107094781A
(en)
*
|
2017-05-22 |
2017-08-29 |
孙金金 |
A kind of composition pesticide and its application containing pyraclonil and dichloro quinolinic acid
|
|
CN106954634A
(en)
*
|
2017-05-22 |
2017-07-18 |
娄天成 |
A kind of composition pesticide and its application containing pyraclonil and anilofos
|
|
CN107114382A
(en)
*
|
2017-05-22 |
2017-09-01 |
娄天成 |
A kind of composition pesticide and its application containing pyraclonil and propanil
|
|
WO2018215535A1
(en)
|
2017-05-23 |
2018-11-29 |
Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) |
Novel cd73 antibody, preparation and uses thereof
|
|
CN107006498A
(en)
*
|
2017-05-24 |
2017-08-04 |
江苏省农用激素工程技术研究中心有限公司 |
Herbicidal combinations for killing weeds in rice field
|
|
RU2653545C1
(en)
*
|
2017-07-17 |
2018-05-11 |
АО "Щелково Агрохим" |
Bentazone-based herbicidal composition for protection of leguminous crops
|
|
US11827669B2
(en)
|
2017-07-19 |
2023-11-28 |
The Usa, As Represented By The Secretary, Dept. Of Health And Human Services |
Antibodies and methods for the diagnosis and treatment of hepatitis b virus infection
|
|
HUE062436T2
(en)
|
2017-08-03 |
2023-11-28 |
Alector Llc |
Anti-trem2 antibodies and methods of use thereof
|
|
MY205541A
(en)
|
2017-08-03 |
2024-10-25 |
Alector Llc |
Anti-cd33 antibodies and methods of use thereof
|
|
EA039662B1
(en)
|
2017-10-03 |
2022-02-24 |
Закрытое Акционерное Общество "Биокад" |
Antibodies specific to cd47 and pd-l1
|
|
RU2698048C2
(en)
|
2017-10-03 |
2019-08-21 |
Закрытое Акционерное Общество "Биокад" |
Monoclonal antibody to il-5rα
|
|
EA202091521A1
(en)
|
2017-12-19 |
2020-10-22 |
Дзе Рокфеллер Юниверсити |
HUMAN Fc IgG DOMAIN OPTIONS WITH IMPROVED EFFECTIVE FUNCTION
|
|
SG11202004158QA
(en)
|
2017-12-28 |
2020-06-29 |
Nanjing Legend Biotech Co Ltd |
Single-domain antibodies and variants thereof against tigit
|
|
CA3084518A1
(en)
|
2018-01-15 |
2019-07-18 |
Nanjing Legend Biotech Co., Ltd. |
Single-domain antibodies and variants thereof against pd-1
|
|
JP7542257B2
(en)
|
2018-01-25 |
2024-08-30 |
エイシーエム バイオラブズ プライベート リミテッド |
Polymersomes containing solubilized encapsulated antigens and methods of making and using same
|
|
CN108371183A
(en)
*
|
2018-02-02 |
2018-08-07 |
河北中天邦正生物科技股份公司 |
A kind of composition pesticide and its application
|
|
CN108308187A
(en)
*
|
2018-02-11 |
2018-07-24 |
河北中天邦正生物科技股份公司 |
A kind of composition pesticide and its application
|
|
AU2019241350B2
(en)
|
2018-03-30 |
2025-10-02 |
Nanjing Legend Biotech Co., Ltd. |
Single-domain antibodies against LAG-3 and uses thereof
|
|
EP3788071A1
(en)
|
2018-05-02 |
2021-03-10 |
The United States Of America, As Represented By The Secretary, Department of Health and Human Services |
Antibodies and methods for the diagnosis, prevention, and treatment of epstein barr virus infection
|
|
CN119841953A
(en)
|
2018-06-08 |
2025-04-18 |
艾利妥 |
Anti-SIGLEC-7 antibodies and methods of use thereof
|
|
CN112469440B
(en)
|
2018-06-18 |
2024-09-06 |
优瑞科生物技术公司 |
Constructs targeting prostate-specific membrane antigen (PSMA) and uses thereof
|
|
SMT202300110T1
(en)
|
2018-07-13 |
2023-05-12 |
Alector Llc |
Anti-sortilin antibodies and methods of use thereof
|
|
KR20210031898A
(en)
|
2018-07-13 |
2021-03-23 |
난징 레전드 바이오테크 씨오., 엘티디. |
Co-receptor system to treat infectious diseases
|
|
SG11202100555PA
(en)
|
2018-07-27 |
2021-02-25 |
Alector Llc |
Anti-siglec-5 antibodies and methods of use thereof
|
|
AR119259A1
(en)
|
2018-08-31 |
2021-12-09 |
Alector Llc |
ANTI-CD33 ANTIBODIES AND METHODS OF USE THEREOF
|
|
WO2020053325A1
(en)
|
2018-09-12 |
2020-03-19 |
Acm Biolabs Pte Ltd |
Polymersomes comprising a covalently bound antigen as well as methods of making and uses thereof
|
|
US12441782B2
(en)
|
2018-09-14 |
2025-10-14 |
The Rockefeller University |
Anti-HIV antibody 10-1074 variants
|
|
US12129305B2
(en)
|
2018-10-25 |
2024-10-29 |
The Medical College Of Wisconsin, Inc. |
Targeting CLPTM1L for treatment and prevention of cancer
|
|
RU2724469C2
(en)
|
2018-10-31 |
2020-06-23 |
Закрытое Акционерное Общество "Биокад" |
Monoclonal antibody which specifically binds to cd20
|
|
JP7627216B2
(en)
|
2018-11-16 |
2025-02-05 |
メモリアル スローン ケタリング キャンサー センター |
Antibodies to mucin-16 and methods of using same - Patents.com
|
|
CN116003597A
(en)
|
2018-11-27 |
2023-04-25 |
舒泰神(北京)生物制药股份有限公司 |
Antibody specifically recognizing granulocyte-macrophage colony-stimulating factor receptor alpha and use thereof
|
|
RU2734432C1
(en)
|
2019-04-23 |
2020-10-16 |
Закрытое Акционерное Общество "Биокад" |
Monoclonal antibody which specifically binds gitr
|
|
US20220226496A1
(en)
|
2019-05-02 |
2022-07-21 |
Legochem Biosciences, Inc. |
Ligand-drug conjugate including linker having tris structure
|
|
IL289219B2
(en)
|
2019-06-28 |
2025-06-01 |
Genentech Inc |
Composition and methods for stabilizing liquid protein formulations
|
|
CN110178842A
(en)
*
|
2019-07-05 |
2019-08-30 |
南京农业大学 |
A kind of pretilachlor and pyraclonil administer resistance barnyard grass composition and its application
|
|
EP3997121A4
(en)
|
2019-07-09 |
2024-03-27 |
Beijing SoloBio Genetechnology Company Ltd. |
ANTIBODIES SPECIFICALLY RECOGNIZING PSEUDOMONAS PCRV AND THEIR USES
|
|
US11634501B2
(en)
|
2019-07-19 |
2023-04-25 |
Oncoresponse, Inc. |
Immunomodulatory antibodies and methods of use thereof
|
|
CN112300279A
(en)
|
2019-07-26 |
2021-02-02 |
上海复宏汉霖生物技术股份有限公司 |
Methods and compositions directed to anti-CD 73 antibodies and variants
|
|
WO2021238886A1
(en)
|
2020-05-27 |
2021-12-02 |
Staidson (Beijing) Biopharmaceuticals Co., Ltd. |
Antibodies specifically recognizing nerve growth factor and uses thereof
|
|
MX2023008485A
(en)
|
2021-01-20 |
2023-07-28 |
Oncoresponse Inc |
Immunomodulatory antibodies and uses thereof.
|
|
WO2022218957A1
(en)
|
2021-04-12 |
2022-10-20 |
Acm Biolabs Pte Ltd |
Polymersomes comprising a soluble encapsulated polynucleotide and an ionizable lipid as well as methods of making and uses thereof
|
|
CN118103397A
(en)
|
2021-07-08 |
2024-05-28 |
舒泰神(加州)生物科技有限公司 |
Antibodies that specifically recognize TNFR2 and uses thereof
|
|
JP7833531B2
(en)
|
2021-07-14 |
2026-03-19 |
舒泰神(北京)生物製薬股フン有限公司 |
Antibodies that specifically recognize CD40 and their use
|
|
EP4445911A4
(en)
|
2021-12-06 |
2025-10-22 |
Beijing Solobio Genetechnology Co Ltd |
BISPECIFIC ANTIBODY WITH SPECIFIC BINDING TO KLEBSIELLA PNEUMONIAE O2 AND O1 ANTIGENS AND COMPOSITION
|
|
EP4524158A4
(en)
|
2022-05-09 |
2025-12-17 |
Staidson Beijing Biopharmaceuticals Co Ltd |
ANTIBODIES SPECIFICALLY RECOGNIZING GDF15 AND ITS USE
|
|
EP4558226A1
(en)
|
2022-07-19 |
2025-05-28 |
Staidson Biopharma Inc. |
Antibodies specifically recognizing b- and t-lymphocyte attenuator (btla) and uses thereof
|
|
WO2024067344A1
(en)
|
2022-09-27 |
2024-04-04 |
舒泰神(北京)生物制药股份有限公司 |
Antibody for specifically recognizing light and use thereof
|
|
CN120693395A
(en)
|
2022-10-20 |
2025-09-23 |
北京三诺佳邑生物技术有限责任公司 |
Antibody combinations and bispecific antibodies that specifically bind to TRAIL or FasL
|
|
EP4725501A1
(en)
|
2023-06-09 |
2026-04-15 |
Staidson (Beijing) Biopharmaceuticals Co., Ltd. |
Antibody specifically binding to masp3, and multi-specific antibody specifically binding to masp3 and masp2
|
|
EP4729546A1
(en)
|
2023-06-16 |
2026-04-22 |
Jiangsu BioJeTay Biotechnology Co., Ltd. |
Antibody specifically recognizing factor xiia and use thereof
|
|
WO2025167631A1
(en)
|
2024-02-05 |
2025-08-14 |
北京三诺佳邑生物技术有限责任公司 |
Multi-specific antibody specifically binding to hbv pre-s1 antigen, pd-l1 antigen and cd3 antigen and use thereof
|
|
WO2025224166A1
(en)
|
2024-04-23 |
2025-10-30 |
F. Hoffmann-La Roche Ag |
Anti-drug antibody assays
|
|
US20260022170A1
(en)
|
2024-05-10 |
2026-01-22 |
Adaptam Therapeutics S.L |
Anti-siglec-9 antibodies and uses thereof
|